D-1341-2019 Class II Terminated

Recalled by Chiesi USA, Inc. — Cary, NC

FDA drug recall D-1341-2019 was initiated by Chiesi USA, Inc. on May 31, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications: Out of specification result for dissolution. The recall status is terminated (terminated Mar 8, 2021). Affected quantity: 2118 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 19, 2019
Initiation Date
May 31, 2019
Termination Date
Mar 8, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2118 bottles

Product description

ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only, Distributed by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-902-12.

Reason for recall

Failed Dissolution Specifications: Out of specification result for dissolution.

Distribution pattern

Nationwide in the USA.

Code information

Lots: 3171855, Exp. 12/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1341-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1341-2019. Report a data issue: hello@regdatalab.com.